The present study confirms the clinical efficacy of omalizumab in patients with severe allergic asthma irrespective of age in a real-life setting outside the omalizumab trial program.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Pulmonary Department, Mainz University Hospital, Mainz, Germany. Stephanie.Korn [at] unimedizin-mainz.de
Ann Allergy Asthma Immunol. 2010 Oct;105(4):313-9
© Galenicom 1999-2013